May 30, 2019
In its latest move to edge deeper into the healthcare sector , Apple has snagged Redwood City, California-based digital startup Tueo Health, which helps parents track their children’s asthma symptoms when they are in bed at night using an under-the-mattress sensor that signals a mobile app to report problems, Business Insider reports.
According to the news outlet, Apple likely was eyeing the digital asthma management company because its product had a good chance of taking off: The global intelligent asthma monitoring market is expected to hit $655 million by 2025—a huge leap from its $20 million valuation in 2017, according to Allied Market Research.
Acquired by Apple in May 2017 and founded in October 2006, Beddit is a Finnish-based technology company that has developed a device that keeps tabs of users’ movement while they’re asleep. Apple likely tapped sleep tracking a growth pillar given that 45% of US adults in 2017 “could imagine” using a sleep tracker, Business Insider said.
Founded in 2013 and purchased by Apple in August 2016, Gliimpse—which targets patients with chronic conditions—offers a consumer-facing platform to combine a user’s personal health data from labs, hospitals, and pharmacies into one shareable report. Apple bought Gliimpse to help turn the iPhone into a repository for consumers’ medical records, helping Apple move into the health records market, per CNBC.
Apple could use all three of these acquisitions to forge new ties with health organizations that want access to valuable sleep data. For example, If Apple can integrate Tueo Health’s solution into its smartphone-based personal medical records hub Health Records, pediatric-focused firms might want to join the horde of hospitals that’ve been flocking to implement it. The tech could provide a fuller picture of how patients are faring at night, which could steer doctors toward the most effective treatment options, Business Insider reports.
This could be a balm to hospitals that are likely racing to get a handle on asthma, which costs the nation $56 billion annually: Over 8% of children—or 6 million total in the United States suffer from asthma, and that number will likely climb, per the Asthma and Allergy Foundation of America (AAFA).
Research contact: @businessinsider